Nos webinaires
When lipids go solid: process strategies to enhance bioavailability in oral dosage forms
Lipid excipients are known to improve the bioavailability of APIs by increasing their solubility and permeability. Generally liquid at room temperature, they are primarily formulated in liquid forms. Solid oral dosage forms (OSDs), such as tablets, can also benefit from the advantages of lipid excipients. This webinar highlights various processes for incorporating lipid excipients into tablets or powders intended for oral administration.
Long-acting veterinary medicines: Less stress, more success
Long acting veterinary formulations are generating growing interest due to their ability to improve therapeutic outcomes, enhance animal welfare, and increase treatment efficiency. This webinar provides key insights into developing sustained release formulations using Gattefossé excipients.
Great science for the smallest things - Innovative solutions for streamlining nanopharmaceutical production
Gattefossé Pharmaceuticals gathers with Skyepharma and RCPE to decipher the innovative solutions for streamlining nanopharmaceutical production. Technical experts will share insights obtained during the NanoFacT consortium.
Beyond the Capsule: Unlocking the Full Potential of Lipid Excipients in Oral Solid Dosage Forms
This presentation from November 4th, 2025 highlights emerging research and practical formulation strategies that expand the use of lipid excipients in oral tablet development, including ternary ASDs, sustained release products, and solid SEDDS formulations.
A toolbox for oral peptide delivery
Oral delivery of peptides encounters many hurdles, as they are subject to degradation in the gastro-intestinal tract, leading to poor oral bioavailability. Different strategies have been developed: the objective of this webinar is to give formulators clues on how to use lipid excipients for enhanced oral peptide delivery.
Advancing Lipid-Based Drug Delivery with Maisine® CC and LiGlass™
In this second webinar of the series, learn how Maisine® CC, an oily vehicle promoting lymphatic uptake and reducing first-pass metabolism, enhances drug absorption when formulated with SeraNovo LiGlass™ platform.
Achieving high drug loading and improved bioavailability in Capryol® 90 with LiGlass™
In this first webinar of the series, discover how Capryol® 90, a powerful solubilizer and intestinal permeation enhancer, integrates with SeraNovo LiGlass™ platform to achieve drug loading and controlled API release for improved bioavailability.
